筛选
科学数据
统计数据
共检索到21条 ,权限内显示50条;
Data from: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy
- 负责人：
- DOI：
- doi:10.5061/dryad.3583v22
- 摘要：
- s: Disease-modifying treatments decreased TTR-FAP excess mortality from ten to four (SMR 3.92, 95% CI 2.64–5.59). Median overall survival of untreated and LTx
RAS-modification as a novel therapy for pulmonary indications in T2D
- 负责人：
- 关键词：
- Clinical and Experimental Therapeutics T2DM angiotensin(1-7) immune function lung fibrosis pulmonary indications
- DOI：
- doi:10.25549/usctheses-c40-350071
- 摘要：
- administration of A(1-7) to db/db mice is effective in prevention of progression of lung disease in db/db mice. Treatment prevented pathological remod
Data from: Revisiting protein aggregation as pathogenic in sporadic Parkinson’s and Alzheimer’s diseases
- 负责人：
- Espay, Alberto J.
- 关键词：
- Parkinson’s disease Alzheimer’s disease biomarkers disease modifying treatments clinical trials
- DOI：
- doi:10.5061/dryad.g1nq02r
- 摘要：
- aggregates may be relevant to common pathology but not to subgroup pathogenesis, and (2) disease-modifying treatments targeting oligomers or fibrils mig
Data from: INTREPAD: a randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
- 负责人：
- 关键词：
- DOI：
- doi:10.5061/dryad.r58d342
- 摘要：
- ng treatment groups combined, the APS increased by 0.101 points/year (S.E = 0.014; P < 10-5), but rate of change showed little difference by treatment assignment
Data from: Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
- 负责人：
- DOI：
- doi:10.5061/dryad.4hk2039
- 摘要：
- , no relevant changes in vital signs or ECG findings observed, and no difference in adverse events between efgartigimod and placebo treatment. All patients
Data from: Blood pressure decreases after revascularization in atherosclerotic renal artery disease: a cohort study based on a multidis
- 负责人：
- DOI：
- doi:10.5061/dryad.3846qt5
- 摘要：
- er of uncontrolled or resistant hypertension (p=0.022 and 0.031) at one-year follow-up. Those parameters were not modified among patients assigned to medical treatment
Data from: Accuracy and readability of cardiovascular entries on Wikipedia: are they reliable learning resources for medical students?
- 负责人：
- DOI：
- doi:10.5061/dryad.q2kg1
- 摘要：
- dability tools. Methods: Wikipedia was searched on the 6 October 2013 for articles on cardiovascular diseases. Using a modified DISCERN (DISCERN is an instrument
Data from: Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
- 负责人：
- DOI：
- doi:10.5061/dryad.32q9q5d
- 摘要：
- research: 1. Pre-clinical studies; 2. Biological and phenotypic heterogeneity; 3. Outcome measures; 4. Disease-modifying and symptomatic intervent
Data from: Serratia marcescens Shapes Cutaneous Bacterial Communities and Influences Survival of an Amphibian Host
- 负责人：
- DOI：
- doi:10.5061/dryad.r556n3j
- 摘要：
- s been differential survival among amphibians in resisting Bd infection and subsequent disease. One factor thought to contribute to this resistance is the host-asso
Data from: Risk factors for suicidality in Huntington's disease: an analysis of the 2CARE clinical trial
- 负责人：
- DOI：
- doi:10.5061/dryad.2hp4hq3
- 摘要：
- for early prediction of suicide attempts in HD may be of value, particularly given anticipated trials aimed at disease modification are likely to be long-term.
